Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-056332

EVP, CFO & CBO sold 107,524 shares at $127.74 ($13,735,116)

  • EVP, CFO & CBO acquired 89,400 shares (option exercise)
  • EVP, CFO & CBO gave 12,012 shares (gift)
  • EVP, CFO & CBO gave 12,012 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-24 Exercise or conversion : show line 1 in the form +9,596 $23.85 $228,865 48,381 D
2018-10-24 Exercise or conversion : show line 2 in the form +39,006 $13.90 $542,183 87,387 D
2018-10-24 Exercise or conversion : show line 3 in the form +29,080 $13.71 $398,687 116,467 D
2018-10-24 Exercise or conversion : show line 4 in the form +11,718 $13.71 $160,654 128,185 D
2018-10-24 Sale : show line 5 in the form −107,524 $127.74 $13,735,116 20,661 D
2018-10-24 Gift : show line 6 in the form −12,012 8,649 D
2018-10-24 Gift : show line 7 in the form +12,012 12,012 I
Open-market sales · 107,524 sh · avg $127.74 · $13,735,116

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-10-24 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −9,596 $23.85 2022-11-05 9,596 116,009 D
2018-10-24 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −39,006 $13.90 2025-02-27 39,006 17,860 D
2018-10-24 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −29,080 $13.71 2026-02-28 29,080 7,899 D
2018-10-24 Exercise or conversion : show line 11 in the form Stock Option (right to buy) −11,718 $13.71 2026-02-28 11,718 12,873 D
Loading xslF345X03/doc4.xml…